Browsing: FDA
Professor25 The U.S. FDA has granted priority review to Verastem Oncology’s (NASDAQ:VSTM) combination of avutometinib and defactinib for a type…
hapabapa Dyne Therapeutics (NASDAQ:DYN) announced Tuesday that the U.S. Food and Drug Administration (FDA) issued fast-track designation for DYNE-101, an…
Innovate (NYSE:VATE) announced today that the U.S. Food and Drug Administration has approved the MediBeacon TGFR for the assessment of…
Innovate (NYSE:VATE) announced today that the U.S. Food and Drug Administration has approved the MediBeacon TGFR for the assessment of…
Andrzej RostekTobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products…
Olivier Le MoalIncyte (NASDAQ:INCY) and Syndax Pharmaceuticals (SNDX) have received FDA approval for their drug Niktimvo in 9 mg and…
Tamer Soliman/iStock via Getty Images4D Molecular Therapeutics (NASDAQ:FDMT) and the U.S. FDA have reached agreement on a phase 3 trial…
JHVEPhotoVanda Pharmaceuticals (NASDAQ:VNDA) has sent a letter to FDA Commissioner Robert Califf asserting that the review of the New Drug…
Denali Therapeutics (NASDAQ:DNLI) announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for tividenofusp alfa for…
GrandbrothersVerastem (NASDAQ:VSTM) stock shot up 20% in after-hours trading on news that the FDA has accepted for priority review the…